Wnt inhibitor
Showing 1 - 25 of 7,436
Myocardial Infarction, Myocardial Fibrosis, Myocardial Remodeling, Ventricular Trial in Messina (P2Y12 Potent Inhibitor +
Recruiting
- Myocardial Infarction
- +2 more
- P2Y12 Potent Inhibitor + Aspirin for STEMI patients
- Clopidogrel + Aspirin for CCS patients
-
Messina, ItalyAOU Policlinico G. Martino
Jan 21, 2023
Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)
Active, not recruiting
- Brain Tumor
- +12 more
- Prexasertib
- +4 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 20, 2022
Klotho _ LRP-6 _ Gastric Adenocarcinoma
Not yet recruiting
- Gastric Adenocarcinoma
- +2 more
- Prognostic study
- (no location specified)
Jan 29, 2023
Endometrial Cancer Trial in Houston (DKN-01, Pembrolizumab)
Not yet recruiting
- Endometrial Cancer
-
Houston, TexasM D Anderson Cancer Center
Feb 27, 2023
Advanced Solid Tumors Trial in South Brisbane (XNW7201 tablets)
Active, not recruiting
- Advanced Solid Tumors
- XNW7201 tablets
-
South Brisbane, Queensland, AustraliaIntegrated Clinical Oncology network Pty Ltd
Jan 4, 2022
Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)
Recruiting
- Cancer
- +11 more
-
San Antonio, TexasSouth Texas Accelerated Research Therapeutics, LLC
Jun 21, 2023
Ischemic Stroke, Acute, Ischemia-reperfusion Injury, Cerebral Edema Trial in Dongguan, Guangzhou (enzyme-linked immunosorbent
Recruiting
- Ischemic Stroke, Acute
- +2 more
- enzyme-linked immunosorbent assay(ELISA)
-
Dongguan, Guangdong, China
- +1 more
Oct 15, 2022
Adamantinous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Binimetinib Oral Tablet
Not yet recruiting
- Adamantinous Craniopharyngioma
- Recurrent Adamantinomatous Craniopharyngioma
- Binimetinib Oral Tablet [Mektovi]
-
Aurora, Colorado
- +17 more
Nov 28, 2022
Hair Loss, Alopecia Trial in Isfahan (Exosome)
Recruiting
- Hair Loss
- Alopecia
- Exosome
-
Isfahan, Iran, Islamic Republic ofLeila Dehghani
Dec 17, 2022
Metastatic Esophageal Cancer, Metastatic Gastric Cancer Trial in Sutton (Atezolizumab)
Recruiting
- Metastatic Esophageal Cancer
- Metastatic Gastric Cancer
-
Sutton, Surrey, United KingdomThe Royal Marsden NHS Foundation Trust
Jul 12, 2021
Colorectal Cancer Metastatic, Skin Toxicity Trial in Milano (Lycopene, Placebo)
Active, not recruiting
- Colorectal Cancer Metastatic
- Skin Toxicity
- Lycopene
- Placebo
-
Milano, ItalyMarco Pirovano
Sep 8, 2021
H. Pylori Infection, Carcinogenesis Trial in Tainan (probiotic)
Recruiting
- H. Pylori Infection
- Carcinogenesis
- probiotic
-
Tainan, TaiwanNational Cheng Kung University & Hospital
Sep 15, 2022
A Retrospective Pharmacogenomics Research of EGFR-TKIs,Gefitinib
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
- +4 more
-
Guangzhou, Guangdong, ChinaCancer Center, Sun Yat-sen University
Oct 25, 2022
IBD Trial in Toulouse (Endoscopic biopsies)
Recruiting
- Inflammatory Bowel Diseases
- Endoscopic biopsies
-
Toulouse, FranceHopital des Enfants
Aug 17, 2022
Glypican-3 asPrognostic Factor in Hepatocellular Carcinoma
Not yet recruiting
- Hepatocellular Carcinoma
- Quantitative assay of GlypicanPC-3
- (no location specified)
May 9, 2022
Colorectal Cancer Trial in Boston (Aspirin, Placebo for Aspirin)
Active, not recruiting
- Colorectal Cancer
- Aspirin
- Placebo for Aspirin
-
Boston, MassachusettsMassachusetts General Hospital
Aug 31, 2022
The Importance of Wnt-signaling After Cardiac Surgery
Completed
- Inflammation
- Thoracic Surgery
- Blood sampling
-
Zürich, SwitzerlandUniversity Hospital
Jul 18, 2022
The Bone-parathyroid Crosstalk in Primary Hyperparathyroidism
Not yet recruiting
- Hyperparathyroidism, Primary
- +2 more
- Biomarker assays
-
Milan, ItalyIRCCS Istituto Ortopedico Galeazzi
Sep 28, 2022
Alopecia Areata Trial in Cairo (the optimized sodium valproate-loaded nanospanlastic dispersion, mometasone furoate lotion)
Not yet recruiting
- Alopecia Areata
- the optimized sodium valproate-loaded nanospanlastic dispersion
- mometasone furoate lotion
-
Cairo, EgyptKasralainy Hospital, Dermatology Department
Aug 20, 2021
Peripheral T Cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)
Recruiting
- Peripheral T Cell Lymphoma
- Linperlisib in combined with Chidamide
-
Beijing, Beijing/China, China
- +1 more
Oct 9, 2023